Darbepoetin Alfa Treatment of Anemia in Hemodialysis Subjects
NCT00119587
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Anemia
Interventions
DRUG:
darbepoetin alfa
Sponsor
Amgen